CN116253833A - Preparation method of dual-template MMPs for specifically adsorbing HC and P - Google Patents
Preparation method of dual-template MMPs for specifically adsorbing HC and P Download PDFInfo
- Publication number
- CN116253833A CN116253833A CN202310349763.6A CN202310349763A CN116253833A CN 116253833 A CN116253833 A CN 116253833A CN 202310349763 A CN202310349763 A CN 202310349763A CN 116253833 A CN116253833 A CN 116253833A
- Authority
- CN
- China
- Prior art keywords
- template
- mmips
- adsorption
- dual
- preparing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108010000684 Matrix Metalloproteinases Proteins 0.000 title claims abstract description 29
- 102000002274 Matrix Metalloproteinases Human genes 0.000 title claims abstract description 29
- 238000002360 preparation method Methods 0.000 title claims abstract description 25
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 claims abstract description 180
- 238000001179 sorption measurement Methods 0.000 claims abstract description 121
- 229960000890 hydrocortisone Drugs 0.000 claims abstract description 90
- 229920000642 polymer Polymers 0.000 claims abstract description 36
- OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 claims abstract description 36
- 229960005205 prednisolone Drugs 0.000 claims abstract description 35
- 238000006116 polymerization reaction Methods 0.000 claims abstract description 24
- 239000011259 mixed solution Substances 0.000 claims abstract description 21
- 229910004298 SiO 2 Inorganic materials 0.000 claims abstract description 20
- 239000000178 monomer Substances 0.000 claims abstract description 20
- 239000003431 cross linking reagent Substances 0.000 claims abstract description 16
- 238000002156 mixing Methods 0.000 claims abstract description 11
- 239000002105 nanoparticle Substances 0.000 claims abstract description 11
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 10
- 239000011246 composite particle Substances 0.000 claims abstract description 9
- 238000001035 drying Methods 0.000 claims abstract description 8
- 239000003999 initiator Substances 0.000 claims abstract description 6
- 238000005303 weighing Methods 0.000 claims abstract description 3
- 229920000344 molecularly imprinted polymer Polymers 0.000 claims description 46
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 45
- 239000000243 solution Substances 0.000 claims description 28
- 238000006243 chemical reaction Methods 0.000 claims description 23
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 17
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 12
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 12
- 230000035484 reaction time Effects 0.000 claims description 11
- 239000008367 deionised water Substances 0.000 claims description 10
- 229910021641 deionized water Inorganic materials 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 239000002245 particle Substances 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 8
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 8
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 claims description 7
- BOTDANWDWHJENH-UHFFFAOYSA-N Tetraethyl orthosilicate Chemical compound CCO[Si](OCC)(OCC)OCC BOTDANWDWHJENH-UHFFFAOYSA-N 0.000 claims description 7
- STVZJERGLQHEKB-UHFFFAOYSA-N ethylene glycol dimethacrylate Substances CC(=C)C(=O)OCCOC(=O)C(C)=C STVZJERGLQHEKB-UHFFFAOYSA-N 0.000 claims description 7
- 239000000696 magnetic material Substances 0.000 claims description 7
- 229910052757 nitrogen Inorganic materials 0.000 claims description 7
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 6
- 238000005406 washing Methods 0.000 claims description 6
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical group N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 claims description 5
- XDLMVUHYZWKMMD-UHFFFAOYSA-N 3-trimethoxysilylpropyl 2-methylprop-2-enoate Chemical group CO[Si](OC)(OC)CCCOC(=O)C(C)=C XDLMVUHYZWKMMD-UHFFFAOYSA-N 0.000 claims description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 5
- 239000006087 Silane Coupling Agent Substances 0.000 claims description 5
- 239000007787 solid Substances 0.000 claims description 5
- DBCAQXHNJOFNGC-UHFFFAOYSA-N 4-bromo-1,1,1-trifluorobutane Chemical compound FC(F)(F)CCCBr DBCAQXHNJOFNGC-UHFFFAOYSA-N 0.000 claims description 4
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims description 4
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims description 4
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 4
- 235000011114 ammonium hydroxide Nutrition 0.000 claims description 4
- 229940040526 anhydrous sodium acetate Drugs 0.000 claims description 4
- 239000006249 magnetic particle Substances 0.000 claims description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 4
- JAHNSTQSQJOJLO-UHFFFAOYSA-N 2-(3-fluorophenyl)-1h-imidazole Chemical compound FC1=CC=CC(C=2NC=CN=2)=C1 JAHNSTQSQJOJLO-UHFFFAOYSA-N 0.000 claims description 3
- KFDVPJUYSDEJTH-UHFFFAOYSA-N 4-ethenylpyridine Chemical compound C=CC1=CC=NC=C1 KFDVPJUYSDEJTH-UHFFFAOYSA-N 0.000 claims description 3
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims description 3
- 229940044631 ferric chloride hexahydrate Drugs 0.000 claims description 3
- 238000001027 hydrothermal synthesis Methods 0.000 claims description 3
- NQXWGWZJXJUMQB-UHFFFAOYSA-K iron trichloride hexahydrate Chemical compound O.O.O.O.O.O.[Cl-].Cl[Fe+]Cl NQXWGWZJXJUMQB-UHFFFAOYSA-K 0.000 claims description 3
- LVHBHZANLOWSRM-UHFFFAOYSA-N methylenebutanedioic acid Natural products OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 claims description 3
- 230000007935 neutral effect Effects 0.000 claims description 3
- 239000003361 porogen Substances 0.000 claims description 3
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 2
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 claims description 2
- 238000009210 therapy by ultrasound Methods 0.000 claims description 2
- 238000002604 ultrasonography Methods 0.000 claims description 2
- 239000000463 material Substances 0.000 abstract description 6
- 235000013305 food Nutrition 0.000 abstract description 4
- 238000010828 elution Methods 0.000 abstract description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 21
- 238000002474 experimental method Methods 0.000 description 15
- 239000012086 standard solution Substances 0.000 description 15
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 14
- 239000000047 product Substances 0.000 description 12
- 238000012360 testing method Methods 0.000 description 12
- 238000004128 high performance liquid chromatography Methods 0.000 description 11
- 235000013336 milk Nutrition 0.000 description 11
- 239000008267 milk Substances 0.000 description 11
- 210000004080 milk Anatomy 0.000 description 11
- 102100028748 Transportin-1 Human genes 0.000 description 10
- 150000001875 compounds Chemical class 0.000 description 10
- 239000000203 mixture Substances 0.000 description 10
- 108010047660 Mitochondrial intermediate peptidase Proteins 0.000 description 9
- 239000006228 supernatant Substances 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 239000002994 raw material Substances 0.000 description 8
- 238000001514 detection method Methods 0.000 description 7
- 125000002133 (4-hydroxy-3-iodo-5-nitrophenyl)acetyl group Chemical group OC1=C(C=C(C=C1I)CC(=O)*)[N+](=O)[O-] 0.000 description 6
- 239000012074 organic phase Substances 0.000 description 6
- 238000011084 recovery Methods 0.000 description 6
- 230000003068 static effect Effects 0.000 description 6
- 229960000583 acetic acid Drugs 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- -1 96%) Chemical compound 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 description 3
- 102100023703 C-C motif chemokine 15 Human genes 0.000 description 3
- 108010082155 Chemokine CCL18 Proteins 0.000 description 3
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 description 3
- 101100382875 Homo sapiens CCL15 gene Proteins 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- LINOMUASTDIRTM-QGRHZQQGSA-N deoxynivalenol Chemical compound C([C@@]12[C@@]3(C[C@@H](O)[C@H]1O[C@@H]1C=C(C([C@@H](O)[C@@]13CO)=O)C)C)O2 LINOMUASTDIRTM-QGRHZQQGSA-N 0.000 description 3
- 229930002954 deoxynivalenol Natural products 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 229960002568 ethinylestradiol Drugs 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000000376 reactant Substances 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 239000000273 veterinary drug Substances 0.000 description 3
- LINOMUASTDIRTM-UHFFFAOYSA-N vomitoxin hydrate Natural products OCC12C(O)C(=O)C(C)=CC1OC1C(O)CC2(C)C11CO1 LINOMUASTDIRTM-UHFFFAOYSA-N 0.000 description 3
- RUDATBOHQWOJDD-UHFFFAOYSA-N (3beta,5beta,7alpha)-3,7-Dihydroxycholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)CC2 RUDATBOHQWOJDD-UHFFFAOYSA-N 0.000 description 2
- 101100129500 Caenorhabditis elegans max-2 gene Proteins 0.000 description 2
- 101100083446 Danio rerio plekhh1 gene Proteins 0.000 description 2
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 238000012662 bulk polymerization Methods 0.000 description 2
- 229960001701 chloroform Drugs 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 238000004817 gas chromatography Methods 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 239000012982 microporous membrane Substances 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 230000004962 physiological condition Effects 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 239000002356 single layer Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000004885 tandem mass spectrometry Methods 0.000 description 2
- RUDATBOHQWOJDD-UZVSRGJWSA-N ursodeoxycholic acid Chemical compound C([C@H]1C[C@@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 RUDATBOHQWOJDD-UZVSRGJWSA-N 0.000 description 2
- 229960001661 ursodiol Drugs 0.000 description 2
- 238000001291 vacuum drying Methods 0.000 description 2
- OZAIFHULBGXAKX-VAWYXSNFSA-N AIBN Substances N#CC(C)(C)\N=N\C(C)(C)C#N OZAIFHULBGXAKX-VAWYXSNFSA-N 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- 206010061459 Gastrointestinal ulcer Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 101000815628 Homo sapiens Regulatory-associated protein of mTOR Proteins 0.000 description 1
- 101000652747 Homo sapiens Target of rapamycin complex 2 subunit MAPKAP1 Proteins 0.000 description 1
- 101000648491 Homo sapiens Transportin-1 Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 101710151803 Mitochondrial intermediate peptidase 2 Proteins 0.000 description 1
- 208000010428 Muscle Weakness Diseases 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 238000000944 Soxhlet extraction Methods 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- PBCJIPOGFJYBJE-UHFFFAOYSA-N acetonitrile;hydrate Chemical compound O.CC#N PBCJIPOGFJYBJE-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000703 anti-shock Effects 0.000 description 1
- 230000001147 anti-toxic effect Effects 0.000 description 1
- 238000010364 biochemical engineering Methods 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000004097 bone metabolism Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000006392 deoxygenation reaction Methods 0.000 description 1
- 150000004683 dihydrates Chemical class 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 230000004406 elevated intraocular pressure Effects 0.000 description 1
- 238000004134 energy conservation Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000013350 formula milk Nutrition 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000007885 magnetic separation Methods 0.000 description 1
- 238000003760 magnetic stirring Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 238000005375 photometry Methods 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000010526 radical polymerization reaction Methods 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000011896 sensitive detection Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- 238000004627 transmission electron microscopy Methods 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- 229940038773 trisodium citrate Drugs 0.000 description 1
- 238000000825 ultraviolet detection Methods 0.000 description 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F222/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical and containing at least one other carboxyl radical in the molecule; Salts, anhydrides, esters, amides, imides, or nitriles thereof
- C08F222/10—Esters
- C08F222/1006—Esters of polyhydric alcohols or polyhydric phenols
- C08F222/102—Esters of polyhydric alcohols or polyhydric phenols of dialcohols, e.g. ethylene glycol di(meth)acrylate or 1,4-butanediol dimethacrylate
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/22—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
- B01J20/26—Synthetic macromolecular compounds
- B01J20/268—Polymers created by use of a template, e.g. molecularly imprinted polymers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/28—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties
- B01J20/28002—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties characterised by their physical properties
- B01J20/28009—Magnetic properties
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F2/00—Processes of polymerisation
- C08F2/44—Polymerisation in the presence of compounding ingredients, e.g. plasticisers, dyestuffs, fillers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
- C08J9/0066—Use of inorganic compounding ingredients
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
- C08J9/009—Use of pretreated compounding ingredients
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
- C08J9/26—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof by elimination of a solid phase from a macromolecular composition or article, e.g. leaching out
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
- C08J9/28—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof by elimination of a liquid phase from a macromolecular composition or article, e.g. drying of coagulum
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K3/00—Use of inorganic substances as compounding ingredients
- C08K3/18—Oxygen-containing compounds, e.g. metal carbonyls
- C08K3/20—Oxides; Hydroxides
- C08K3/22—Oxides; Hydroxides of metals
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K3/00—Use of inorganic substances as compounding ingredients
- C08K3/34—Silicon-containing compounds
- C08K3/36—Silica
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K9/00—Use of pretreated ingredients
- C08K9/04—Ingredients treated with organic substances
- C08K9/06—Ingredients treated with organic substances with silicon-containing compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2201/00—Foams characterised by the foaming process
- C08J2201/04—Foams characterised by the foaming process characterised by the elimination of a liquid or solid component, e.g. precipitation, leaching out, evaporation
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2201/00—Foams characterised by the foaming process
- C08J2201/04—Foams characterised by the foaming process characterised by the elimination of a liquid or solid component, e.g. precipitation, leaching out, evaporation
- C08J2201/042—Elimination of an organic solid phase
- C08J2201/0422—Elimination of an organic solid phase containing oxygen atoms, e.g. saccharose
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2335/00—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical, and containing at least one other carboxyl radical in the molecule, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Derivatives of such polymers
- C08J2335/02—Characterised by the use of homopolymers or copolymers of esters
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K3/00—Use of inorganic substances as compounding ingredients
- C08K3/18—Oxygen-containing compounds, e.g. metal carbonyls
- C08K3/20—Oxides; Hydroxides
- C08K3/22—Oxides; Hydroxides of metals
- C08K2003/2265—Oxides; Hydroxides of metals of iron
- C08K2003/2275—Ferroso-ferric oxide (Fe3O4)
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K2201/00—Specific properties of additives
- C08K2201/01—Magnetic additives
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N2030/022—Column chromatography characterised by the kind of separation mechanism
- G01N2030/027—Liquid chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
- G01N2030/062—Preparation extracting sample from raw material
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Inorganic Chemistry (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Steroid Compounds (AREA)
Abstract
The invention discloses a preparation method of double-template MMIPs for specifically adsorbing hydrocortisone HC and prednisolone P, which belongs to the technical field of polymer adsorption materials and comprises the following steps: preparation of Fe 3 O 4 A nanoparticle; preparation of Fe 3 O 4 @SiO 2 Composite particles; preparation of Fe 3 O 4 @SiO 2 -c=c; preparing double-template MMPs: mixing each template molecule (HC and P) with a functional monomer and a pore-forming agent respectively, dissolving, and imprinting at room temperature to obtain a first mixed solution; weighing Fe 3 O 4 @SiO 2 C=c, adding a pore-forming agent, uniformly dispersing, mixing with the first mixed solution, and sequentially adding a crosslinking agent and an initiator to perform polymerization reaction; and then collecting the product, drying and Soxhlet extracting to obtain the polymer with the specific cavity. The dual-template MMIPs prepared by the application can specifically adsorb, enrich and detect trace HC and P remained in food, and have the reusability of continuous use after elution.
Description
Technical Field
The invention belongs to the technical field of polymer adsorption materials, and particularly relates to a preparation method of a double-template Magnetic Molecularly Imprinted Polymer (MMIPs) for specifically adsorbing Hydrocortisone (HC) and prednisolone (P).
Background
Hydrocortisone (HC), also known as cortisol, is one of the adrenoglucocorticoid drugs and has mainly anti-inflammatory, immunosuppressive, antitoxic and antishock effects, but excessive or prolonged intake of hydrocortisone can cause serious side effects including obesity, blood sugar, blood pressure and elevated intraocular pressure, muscle paralysis, gastrointestinal ulcers and even bleeding perforations. Since hydrocortisone can be used as a veterinary drug, its residues in agricultural and sideline products are potentially dangerous to humans. The European Union, the United states, etc. prescribes a limiting standard of up to 10 mug/kg for residual hydrocortisone in milk. Prednisolone (P) also belongs to adrenoglucocorticoid medicines, is mainly used for resisting inflammation and allergy, and is used as veterinary medicine for treating animal inflammation. Similar to hydrocortisone, excessive or prolonged intake of prednisolone can also cause side effects such as abnormal bone metabolism, hypoadrenocortical function, muscle weakness, elevated blood glucose, blood lipid, sodium blood, etc. Therefore, prednisolone is also a veterinary drug residue subject of great concern in agricultural and sideline products, and the highest residue limit in domestic milk standards is 6 mug/kg.
Currently, the common methods for detecting the two substances include fluorescence photometry, gas chromatography, high performance liquid chromatography, gas chromatography tandem mass spectrometry, high performance liquid chromatography tandem mass spectrometry and the like, and the methods are complex in operation or require complex pretreatment steps of the to-be-detected substances, so that the detection speed is slow. The molecular imprinting technology is a novel pretreatment method, and utilizes Molecular Imprinting Polymers (MIPs) to adsorb substances to be detected for enrichment, and the principle is that functional monomers, cross-linking agents and template molecules are polymerized to obtain a polymer with a three-dimensional network structure, and then the template molecules are eluted, so that binding sites matched with the size and the shape of the template molecules can be left on the polymer, and the binding sites can adsorb target substances again to achieve the purpose of specific adsorption. The Magnetic Molecularly Imprinted Polymer (MMIPs) combined with the magnetic separation technology adds Fe on the basis of MIPs 3 O 4 The nano particles are used as magnetic cores, so that the whole polymer can be separated from the to-be-detected product through the action of an external magnetic field, the convenience of a molecular imprinting technology is further enhanced, and the energy conservation and the environmental protection are realized.
Therefore, the specificity sensitive detection of hydrocortisone and prednisolone in agricultural and sideline products is realized, and the method has quite important practical significance and application prospect for rapid detection of pesticide and veterinary drug residues in foods.
Disclosure of Invention
The invention aims to provide a preparation method of a dual-template magnetic molecularly imprinted polymer for specifically adsorbing Hydrocortisone (HC) and prednisolone (P), and the preparation method successfully synthesizes a three-dimensional structure with a specific cavity for a target compound, so that the hydrocortisone and the prednisolone have larger adsorption capacity and better specific adsorption capacity.
The invention aims at realizing the following technical scheme:
a preparation method of dual-template MMPs for specifically adsorbing HC and P comprises the following steps:
s1, preparing Fe with carboxyl on surface by improved hydrothermal method 3 O 4 A nanoparticle;
s2, preparing Fe 3 O 4 @SiO 2 Composite particles;
s3, preparing Fe 3 O 4 @SiO 2 -C=C;
S4, preparing a dual-template magnetic molecularly imprinted polymer: mixing each template molecule with a functional monomer and a pore-forming agent respectively, dissolving, and imprinting at room temperature to obtain a first mixed solution; weighing Fe obtained in the step S3 3 O 4 @SiO 2 -c=c, adding a porogenic agent, uniformly dispersing the magnetic material by ultrasound, and mixing with the first mixed solution to obtain a second mixed solution; then adding a cross-linking agent and an initiator into the second mixed solution in sequence to carry out polymerization reaction; heating after deoxidizing the nitrogen; after the reaction, the product is collected by a magnetic field, dried and Soxhlet extracted to obtain a polymer with a specific cavity, wherein the template molecules are hydrocortisone HC and prednisolone P.
Further, the step S1 specifically includes: adding ferric chloride hexahydrate, trisodium citrate dihydrate and ethylene glycol into a beaker, magnetically stirring at room temperature until solid particles are dissolved, then adding anhydrous sodium acetate, and stirring until the solution is uniform; pouring the solution into a reactor, and reacting for 10 hours at 200 ℃; after the reaction, magnetic particles are separated by applying a magnetic field, repeatedly washed by deionized water and ethanol, and dried to obtain Fe with carboxyl on the surface 3 O 4 A nanoparticle;
the step S2 specifically includes: taking Fe synthesized in the step S1 3 O 4 Dispersing the nano particles in hydrochloric acid solution, carrying out ultrasonic treatment, collecting magnetic materials by using a magnet, and washing to be neutral; dispersing the washed particles in a mixture of ethanol and deionized waterAdding tetraethyl orthosilicate and 28wt% ammonia water solution into the mixed solution respectively, and stirring at normal temperature for reaction; separating, washing and drying after the reaction to obtain Fe 3 O 4 @SiO 2 Composite particles;
the step S3 specifically includes: taking Fe synthesized in the step S2 3 O 4 @SiO 2 Dispersing composite particles in methanol water solution added with silane coupling agent, stirring, separating, washing and drying to obtain Fe 3 O 4 @SiO 2 -C=C。
Further, the silane coupling agent is gamma-methacryloxypropyl trimethoxysilane.
Further, the functional monomer is any one of acrylamide, methacrylic acid, 4-vinyl pyridine and itaconic acid.
Further, the pore-forming agent is any one of acetonitrile, ethanol, chloroform and tetrahydrofuran. The selection of the pore-forming agent not only affects the pre-polymerization of the functional monomer and the template molecule, but also has great influence on the selection of the eluting solvent, the preparation of the adsorption solution and the chromatographic conditions.
Further, the time for imprinting at room temperature is 3-24 h.
Further, the cross-linking agent is any one of ethylene glycol dimethacrylate, tetraethyl orthosilicate and divinylbenzene; the initiator is 2, 2-azo diisobutyronitrile.
In step S4, the addition ratio of the template molecule, the functional monomer and the crosslinking agent is 1:1-10:5-50.
Further, the temperature for polymerization reaction is 55-75 ℃; the reaction time is 3-24 h.
Further, the polymerization reaction is carried out at a temperature of 60 ℃; the polymerization reaction was carried out for 6 hours.
1. The preparation method of the dual-template MMIPs for specifically adsorbing hydrocortisone HC and prednisolone P comprises the steps of firstly pre-arranging enough functional monomers which can be anchored with template molecules to the greatest extent in space with the template molecules to form a pre-polymerized compound, mixing the pre-polymerized compound with a certain proportion of cross-linking agent and initiator, introducing inert gas, deoxidizing and sealing, and performing free radical polymerization by utilizing thermal initiation to obtain high-molecular polymer solid with larger volume, and obtaining polymer particle products with proper particle diameters after cleaning, drying, crushing, grinding and sieving; finally, removing the template molecules from the polymer structure through solvent extraction, thereby obtaining the highly cross-linked molecularly imprinted polymer with high specificity and adsorption capacity for hydrocortisone HC and prednisolone P. According to the invention, the three-dimensional structure with specific cavities for hydrocortisone HC and prednisolone P is successfully synthesized through the synthetic polymer, so that the hydrocortisone and the prednisolone have larger adsorption capacity and better specific adsorption capacity.
2. The magnetic molecularly imprinted polymer prepared by the invention can not only specifically adsorb, enrich and detect residual trace hydrocortisone and prednisolone in food, but also has stable and specific adsorption capacity on target compounds through a specific cavity with a fixed shape, so that the magnetic molecularly imprinted polymer can keep higher adsorption capacity even in multiple elution-adsorption operations, has reusability for continuous use after elution, is simple and convenient in separation means from a detected product, and has sufficient application potential in the field of food impurity detection.
Drawings
FIG. 1 is a graph of experimental criteria for linear relationship of Hydrocortisone (HC) and prednisolone (P) according to the present invention; wherein a is a hydrocortisone standard curve; b is a prednisolone standard curve;
FIG. 2 is a single-factor adsorption capacity histogram for the polymerization experimental feedstock screen of example 4;
FIG. 3 is a molar ratio one-factor adsorption capacity histogram of the polymerization experiment in example 4;
FIG. 4 is a graph of the time stamped single factor results of example 4;
FIG. 5 is a graph of the polymerization temperature one-factor results in example 4;
FIG. 6 is a graph of the polymerization time single-factor results in example 4;
FIG. 7 is a graph of the static adsorption test of the magnetic molecularly imprinted polymer in example 4;
FIG. 8 is a graph of the static adsorption fit of the magnetic molecularly imprinted polymer of example 4; wherein graph A, B is a Langmuir fit for HC and P, respectively, and graph C, D is a Freundlich fit for HC and P, respectively;
FIG. 9 is a graph of dynamic adsorption test of magnetic molecularly imprinted polymer in example 4;
FIG. 10 is a graph of the dynamic adsorption kinetics fit of the magnetic molecularly imprinted polymer of example 4; wherein graph A, B is a first order kinetic fit to HC and P, respectively, and graph C, D is a second order kinetic fit to HC and P, respectively;
FIG. 11 is a repetitive adsorption cycle bar chart in example 4;
FIG. 12 is a graph of the adsorption capacity of the selectivity experiment in example 4.
Detailed Description
For better understanding of the content of the patent of the present invention, the following detailed description of the embodiments of the present invention is provided for the purpose of providing detailed embodiments and specific operation procedures on the premise of the technical solution of the present invention, but the content of the present invention is not limited to the following examples.
The reagents, materials and instrument sources involved in the examples of the present invention are shown below:
reagent and material (check): acrylamide (AM, 99%), methacrylic acid (MAA, 98%), 4-vinylpyridine (4-VP, 96%), ethylene glycol dimethacrylate (EGDMA, 99%), divinylbenzene (DVB, 80%), 2-azobisisobutyronitrile (AIBN, 99%), hydrocortisone (HC, 98%), ursodeoxycholic acid (UA, 99%), γ -methacryloxypropyl trimethoxysilane (silane coupling agent, KH 570), prednisolone (Pre, 98%), itaconic acid (IA, 99%), acetonitrile (MeCN), trichloromethane, tetrahydrofuran (THF), tetraethyl orthosilicate (TEOS), hydrochloric acid, ethylene glycol and anhydrous sodium acetate, all available from national pharmaceutical chemicals limited; absolute ethanol and methanol were purchased from stannous biochemical engineering limited; glacial acetic acid, aqueous ammonia, and dihydrate, trisodium citrate are all purchased from south Beijing chemical agents, inc.; chromatographic acetonitrile was purchased from Shanghai Sixinbiotech Co. The above reagents were all analytically pure unless otherwise specified.
Self-matching reagent:
(1) Hydrocortisone standard solution: 5mg of hydrocortisone was fixed in a 10mL volumetric flask with acetonitrile to prepare a standard solution with a concentration of 500ug/mL, which was diluted to the desired concentration for subsequent experiments.
(2) Prednisolone standard solution: 5mg of prednisolone is fixed in a 10mL volumetric flask with acetonitrile to prepare a standard solution with the concentration of 500ug/mL, and the standard solution is diluted to the required concentration by a subsequent experiment.
The main instrument is as follows: fourier transform infrared spectrometer (FT-IR) model tensor 27 (Bruker, germany), scanning Electron Microscope (SEM), regulatory 8100 (japan); transmission electron microscopy, TGA4000, perkin elmer, usa; vibrating sample magnetometer VSM-7404 (lasesshore, U.S.A.); high Performance Liquid Chromatography (HPLC) lc-20at,Shimadzu Japan using an inorganic phosphorus C18 column (4.6I.DX250 mm,5mm, shimadzuGL, shanghai).
Example 1: preparation of Magnetic Molecularly Imprinted Polymers (MMIPs)
The specific preparation process of the dual-template Magnetic Molecularly Imprinted Polymer (MMIPs) for specifically adsorbing hydrocortisone and prednisolone is as follows:
1. improved hydrothermal method for preparing Fe with carboxyl on surface 3 O 4 A nanoparticle;
4.5g of ferric chloride hexahydrate, 1.245g of trisodium citrate dihydrate and 150ml of ethylene glycol were added to the beaker, magnetically stirred at room temperature until the solid particles dissolved, and 7.2g of anhydrous sodium acetate was slowly added to the mixed solution, magnetically stirred at 30 ℃ for 30 minutes. The solution was poured into a reactor and reacted at 200℃for 10 hours. After the reaction, the magnetic particles were separated by applying a magnetic field and repeatedly washed with deionized water and ethanol until the solution was clear. Drying the cleaned magnetic particles in a vacuum drying oven at 55deg.C for 6 hr to obtain Fe with carboxyl on surface 3 O 4 And (3) nanoparticles.
2. Preparation of Fe 3 O 4 @SiO 2 Composite particles;
0.75g of synthesized Fe is weighed 3 O 4 Nanoparticles were dispersed in 150ml of 0.1% (v/v) hydrochloric acid solution, sonicated for 10 minutes, the magnetic material was collected with a magnet and washed with deionized water until it was neutral. The washed particles were dispersed in 120ml of ethanol and 30ml of deionized water, 3.75ml of tetraethyl orthosilicate and 7.5ml of 28wt% aqueous ammonia solution were added to the solutions, respectively, and mechanically stirred at 30℃for 12 hours. After the reaction, the magnetic material was collected by applying a magnetic field and washed with deionized water and ethanol until the solution was clear. Drying the cleaned particles in a vacuum drying oven at 55deg.C for 12 hr to obtain Fe 3 O 4 @SiO 2 And (3) composite particles.
3. Preparation of Fe 3 O 4 @SiO 2 -C=C;
0.5g of synthesized Fe is weighed 3 O 4 @SiO 2 This was dispersed in 100ml of 80% (v/v) aqueous methanol to which 2ml of gamma-methacryloxypropyl trimethoxysilane was added, and magnetically stirred at 70℃for 24 hours under nitrogen protection. After the reaction, the magnetic substance was separated by a magnetic field, and the product was washed with methanol. The cleaned material was dried in a vacuum oven at 55℃for 3h.
4. Preparation of Dual-template magnetic molecularly imprinted Polymer
Mixing 0.2mmol of hydrocortisone and prednisolone with 2mmol of acrylamide and 20ml of acetonitrile respectively, performing ultrasonic operation for 30min to dissolve the solid, and imprinting for a certain time at room temperature. Weigh 0.2g Fe 3 O 4 @SiO 2 -c=c, adding 20ml acetonitrile, sonicating for 30min, allowing the magnetic material to disperse homogeneously, and mixing with the solution with template molecules added as described before. To the mixed solution, 20mmol of ethylene glycol dimethacrylate and 50mg of N, N-azobisisobutyronitrile were sequentially added. After deoxygenation with nitrogen for 15min, magnetic stirring was performed at 60℃for 12h. After the reaction, the product was collected by magnetic field and dried in a vacuum oven at 55 ℃ for 6h. Soxhlet extraction of the dried product in 150ml of methanol/acetic acid=9/1 (v/v) solution at 80℃for 24 hours and more, until detection by UV spectrophotometry at 245nm and 240nmHC or P could not be detected to obtain a polymer with specific cavities.
Example 2: preparation of magnetic non-molecularly imprinted polymers (MNIPS)
The preparation method of this example was the same as that of example 1, except that the template molecule was not added.
Example 3: test of Linear relation
The hydrocortisone and prednisolone standard solutions are diluted to be 1, 2, 5, 10, 20, 50, 100, 125 and 250 mug/mL in a gradient manner, three parallel concentrations are set in each group, a high performance liquid chromatography ultraviolet detector is used for injecting samples with the concentrations for analysis, and a standard curve is drawn by taking the standard concentration as an abscissa (X, mug/mL) and the peak area of a chromatogram as an ordinate (Y). The chromatographic column is as follows: inertSustatin C18 column (4.6 i.D. times.250 mm,5 mm), mobile phase deionized water and acetonitrile, solvent ratio deionized water: acetonitrile=45:55 (V/V), flow rate was set at 1ml/min, column temperature 35 ℃, sample volume 10 μl. The ultraviolet detection wavelength was 254nm. The standard graph is shown in fig. 1.
As shown in FIG. 1, the results in FIG. A show that the concentration of HC and the peak area in the range of 1-500. Mu.g/mL have a good linear relationship, Y=24668X-71350 (R= 0.9996), the detection limit is 2.9ng/mL, the quantitative limit is 9.1ng/mL, and the effective measurement of HC under physiological conditions can be performed.
The results in panel B show that the concentration of P in the range of 1-500 μg/mL has a good linear relationship with peak area, y= 24192X-77584 (r=0.9997), the detection limit is 1.3ng/mL, the quantification limit is 4.7ng/mL, and effective measurement of P under physiological conditions can be performed.
Example 4: performance measurement
(one) static adsorption test
1. Single factor screening of functional monomers, cross-linking agents and porogens selected for the preparation of MIPs and NIPs
The experimental group of 11 different raw material combinations was named MIPs1 to MIPs11, and the following MIPs and the respective NIPs were prepared according to the preparation steps of the molecularly imprinted polymer, and according to the raw material combinations of the functional monomers, the crosslinking agent, and the porogen in table 1. 10mg of MIPs and NIPs were weighed out respectively, 2ml of hydrocortisone standard solution having a concentration of 50. Mu.g/ml was added thereto, and the mixture was stirred and shaken at 25℃for 3 hours. After the adsorption, the mixture was passed through a 0.22 μm organic phase microporous membrane and analyzed by high performance liquid chromatography.
The adsorption capacity (mg/g) of the polymer at which adsorption equilibrium was reached was noted Qe; the initial concentration (. Mu.g/ml) of the hydrocortisone standard solution was designated C 0 The concentration of hydrocortisone in the solution after reaching the adsorption equilibrium (μg/ml) was noted as Ce, the volume of the added standard solution (ml) was noted as V, and the mass of the added imprinted polymer (g) was noted as m, and the equilibrium adsorption capacity Qe was determined as follows:
the ratio of adsorption capacity of MMPs and MNIPS to template molecules is distinguished by the imprinting factors, and the larger the imprinting factors are, the more the adsorption capacity of MMPs is higher than that of MNIPS, and the more the adsorption capacity of MMPs to template molecules is specific.
Wherein QMIPs and QMINIPs (mg/g) represent adsorption capacities of MMIPs and MNIPs to respective template molecules.
The single factor combinations and Qe data used are shown in table 1 and the data histogram is shown in fig. 2.
Table 1: single factor table for screening polymerization experimental raw materials
As can be seen from Table 1 and FIG. 2, MIP 3, MIP 4, MIP 7 and MIP 9 have higher Qe values of 7.98mg/g, 8.065mg/g, 9.136mg/g, 8.126mg/g and 8.978mg/g, respectively, and can realize high adsorption capacity for HC.
Whereas MIP1, MIP 4, MIP5 and MIP 8 possess excellent IF values of 2.025, 1.813, 2.61 and 8.04, respectively, which can satisfy specific selectivity to HC. In order to obtain a polymer with high adsorption capacity and specific recognition capacity at the same time, the adsorption capacity and the IF value need to be comprehensively considered, and finally MIPs4 are selected, namely AM is taken as a functional monomer, EGDMA is taken as a cross-linking agent, and MeCN is taken as a pore-forming agent to be taken as an optimal raw material combination.
2. Determining the addition proportion of the combination of the screened functional monomer, the cross-linking agent and the template molecule
The preparation method comprises the steps of setting 8 groups of experimental groups with different molar ratios to be MIP 1-8, preparing corresponding MIPs, NIPs and Qe according to the raw material molar ratios in the table 2 by using the optimal raw material combination obtained in the static adsorption experiment 1, namely the combination of AM as a functional monomer, EGDMA as a crosslinking agent and MeCN as a pore-forming agent according to the preparation steps of the molecularly imprinted polymer. The data histogram is shown in fig. 3.
TABLE 2 Single factor table for mole ratio screening of polymerization experiments
From the analysis of Table 2 and FIG. 3, it can be concluded that too large a proportion of template molecules or too small a proportion of cross-linking agent can affect the production of MIPs, such as MIP 2, MIP 4, MIP5, and MIP 7, while too small a proportion of functional monomer to cross-linking agent can affect the cross-linking of NIPs, such as MIP5 and MIP 7.MIP Qe is 7.521-8.813mg/g, NIP Qe is 5.104-6.645mg/g, and MIP 6 is found to reach IF value of 1.727, and the molecular engram polymer is prepared according to the raw material molar ratio.
3. Study of the time of the MIPs bulk Pre-polymerization blotting (also called Pre-polymerization)
5 sets of blotting times (3 h,6h,12h,18h,24 h) were set, each set of experiments was run in triplicate, and the optimal blotting time was screened using Qe for HC as an indicator. The experimental results are shown in table 3 and fig. 4.
TABLE 3 time stamp single factor table
The pre-polymerization time affects the formation of template molecule-functional monomer complexes. The template molecule and the functional monomer are paired by intermolecular force, so that the template molecule and the functional monomer need to be sufficiently reacted by incubation for a proper time.
From the experimental results, qe shows a trend of rising and then falling along with the increase of the imprinting time, and the maximum adsorption capacity is 8.42mg/g when the imprinting time reaches 12h, so that the pre-polymerization time of template molecules and functional monomers is selected before the synthesis of the polymer is 12h.
4. Investigation of reaction temperature of bulk polymerization of MIPs
Because the structure of the reactant can be damaged due to the excessively high reaction temperature, the final product is hard, the reaction temperature is too low, the reaction is slow, the polymerization reaction is incomplete, and the adsorption effect is affected, 5 groups of reaction temperatures (55 ℃,60 ℃,65 ℃,70 ℃,75 ℃) are set, and each group of experiments are performed in parallel for three times, so that the optimum reaction temperature is screened by taking Qe of HC as an index. The experimental results are shown in table 4 and fig. 5.
TABLE 4 polymerization temperature one-factor Table
The reaction temperature affects how fast the reaction occurs and the nature of the reactants. It is therefore necessary to conduct experiments with the reaction temperature as a single variable. As can be seen from Table 4 and FIG. 5, the adsorption amount Qe of the polymer increases gradually as the reaction temperature increases, and then decreases gradually, and the maximum adsorption capacity is 8.453mg/g at 60 ℃. After exceeding 60 ℃, the Qe value is continuously reduced with the increase of the temperature, probably due to the fact that the temperature is too high, the generated product is hardened, and the rigidity of the formed crosslinked polymer is too high, so that the adsorption effect is reduced. According to the results, 60℃was finally selected as the optimal reaction temperature for polymer synthesis.
5. Study of reaction time of bulk polymerization of MIPs and NIPs
Since the ideal specific adsorption effect cannot be achieved completely due to the short reaction time, the excessive reaction time may cause the massive reactants to be too hard for subsequent treatment, and therefore, 5 groups of reaction time (3 h,6h,12h,18h and 24 h) are set, and the appropriate reaction time is screened by taking Qe of HC as an index, and experimental results are shown in Table 5 and FIG. 6.
TABLE 5 polymerization time one-factor Table
The experimental results are shown in table 5 and fig. 6. It can be seen that when the reaction time is 6 hours, qe reaches a maximum of 8.704mg/g, and the continuous increase of the reaction time Qe does not only cause a significant increase, but also gradually decreases with the increase of the polymerization reaction time, and the adsorption specificity of the polymer synthesized for 6 hours reaches a maximum, IF is 1.973, so that 6 hours is selected as the optimal reaction time for synthesizing the polymer.
6. Testing the maximum adsorption Capacity of double template MMPs and template-free MNIPS Polymer molecules on Hydrocortisone (HC) and prednisolone (P)
10mg of MMIPs and MNIPs are respectively weighed accurately, 2ml of mixed standard solution (1-250 mug/ml, obtained by re-diluting standard solution of HC and P with acetonitrile water solution and mixing the two solutions with the same concentration) with different concentrations is added, and stirring and shaking are carried out for 3 hours at 25 ℃. After the adsorption is finished, the mixed solution is passed through a 0.22 mu m organic phase microporous filter membrane and subjected to high performance liquid chromatography analysis to determine the residual hydrocortisone and prednisolone concentrations in the mixed solution. The experimental results are shown in table 6 and fig. 7.
Table 6 adsorption capacity meter for static adsorption experiment
As shown in FIG. 7, the dual-template magnetic molecularly imprinted polymer has good adsorption capacity on hydrocortisone and prednisolone and has a concentration of 125 mug ml -1 Before, as the initial concentration increases, the adsorption capacity tends to increase more, and the adsorption capacity increases more slowly after 125. Mu.g ml-1. At 125 mug ml-1, MMIPs have an adsorption capacity of 16.708mg/g for HC, an adsorption efficiency of 78.6%, an adsorption capacity of 16.708mg/g for Pre, an adsorption efficiency of 83.23%, and IF of 1.918 and 2.229 respectively. The graph shows that the thermodynamic curve growth rate of MNIPS is slower than that of MMIPs, and the difference between the adsorption capacity of MNIPS and the adsorption capacity of MMIPs gradually increases along with the increase of the initial concentration, so that the MMIPs have better specific adsorption capacity to target molecules, and the MMIPs form specific cavities of template molecules HC and P, so that the template molecules have higher adsorption capacity.
7. Static adsorption experimental data analysis
The binding pattern and adsorption process of the polymer were described using Langmuir and Freundlich fitting models for analysis:
freundlich fitting model: logQ e =(1/n)logC e +logK F
Wherein Qmax (mg/g) is the theoretical maximum adsorption capacity, K, of the polymer L Is the langmuir adsorption coefficient, KF is the Freundlich adsorption coefficient, and n is the Freundlich adsorption constant. The various coefficients in the two fitting curves of MMPs and MNIPs are shown in the following table, and the two fitting curves of MMPs and MNIPs on HC and P adsorption are shown in FIG. 8.
TABLE 7 Langmuir and Freundlich fitting Curve correlation coefficients of Hydrocortisone (HC) and prednisolone (P)
Table 7 and FIG. 8 show that the R of HC MMPs and MNIPs is known from the curve trend 2 The values are 0.9812 and 0.9454 respectively, the fitting degree of the dual-template magnetic molecularly imprinted polymer to the fitting curve of HC is the same as that of the fitting curve of L and F, and R of L in the fitting curve of prednisolone 2 The values were greater than F, so the fitted curve was more consistent with the L model, indicating that the adsorption of the polymer to hydrocortisone included both monolayer adsorption present on the surface and adsorption by hydrogen bonding, whereas prednisolone was predominantly monolayer adsorption, with recognition sites present on the molecular surface. Q of MMIPs according to the data of Table 7 max 、K L 、K F The n is higher than MNIPS, which proves that MMPs have better adsorption effect and better selective adsorption capability on template molecules hydrocortisone and prednisolone.
(II) dynamic adsorption test
1. 10mg of MMPs and MNIPs were weighed accurately, 2ml of mixed standard solution of hydrocortisone and prednisolone (each concentration 50. Mu.g/ml before mixing) was added, and the mixture was adsorbed at 25℃for different times (1-240 min). The mixed solution was then passed through a 0.22 μm organic phase microporous filter and then subjected to high performance liquid chromatography to determine the concentrations of residual HC and P in the liquid. The dynamic adsorption curves of MMPs and MNIPs to HC and P are shown in FIG. 9, and the experimental results are shown in Table 8.
Table 8 adsorption capacity table for dynamic adsorption experiments
As can be seen from FIG. 9, the adsorption capacities of MMIPs of HC and P are rapidly increased within 5min, then the acceleration is slowed down within 5-30min, and the adsorption capacities are slowly increased within 30-90min until the adsorption equilibrium is reached within 90min, and the adsorption equilibrium time of MNIPs is 120min. Meanwhile, the adsorption capacities of MMIPs of HC and P are 8.412mg/g and 7.898mg/g respectively, and MNIPS adsorption capacities of HC and P are 3.778mg/g and 3.812mg/g respectively, which indicate that the polymer is successfully synthesized to have a three-dimensional structure with a specific cavity for a target compound, so that the polymer has larger adsorption capacities for HC and P, and better adsorption capacity for HC and P.
2. And fitting data of a dynamic adsorption experiment by using a primary dynamic model and a secondary dynamic model, so as to know the adsorption mechanism of the polymer and the change of the adsorption rate of the polymer.
First-order dynamics model: ln (Q) e -Q t )=lnQ max1 -k 1 t
wherein Q is max1 And Q max2 (mg/g) theoretical maximum adsorption capacity of polymer in primary and secondary kinetic models, Q t (mg/g) is the adsorption capacity, k, of the polymer at time t 1 And k 2 (min -1 ) Is the first and second adsorption rate constants, and t (min) is the adsorption time. The various coefficients in the two kinetic models of MMIPs and MNIPs are shown in table 9, and the corresponding kinetic fit graphs are shown in fig. 10.
TABLE 9 first and second order kinetic fit curve correlation coefficients for Hydrocortisone (HC) and prednisolone (P)
Table 9 and FIG. 10 show that R of the fitted curve is analyzed 2 The values are known, HC andthe second-order kinetic curves of MMIPs and MNIPs of P have the best fitting performance compared with the first-order kinetic curves, which shows that the surface of the polymer has saturated adsorption sites, and adsorption reaches a certain degree, so that adsorption equilibrium is achieved. Q of MMPs in the secondary kinetic profile of P max2 、k 2 All are larger than MNIPs, which indicates that MMPs have more excellent selectivity on P and have larger adsorption effect.
(III) repeatability test
10mg MMPs and MNIPS are respectively placed into different centrifuge tubes, 2ml of hydrocortisone and prednisolone standard solution diluted to 50 mug/ml are added into the centrifuge tubes, the mixture is adsorbed for 2 hours in a constant temperature shaking table at 25 ℃, the supernatant is separated by using an external magnetic field after the completion, and the supernatant is filtered through a 0.22 mu m organic microporous filter membrane for testing the residual hydrocortisone and prednisolone content in the solution by HPLC. The magnetic molecularly imprinted polymer obtained by the applied magnetic field was collected, mixed with 2ml of a methanol/acetic acid (9:1, v/v) mixture, separated by the applied magnetic field after 5min, and dried. The above procedure was repeated six times in total.
The adsorption capacity Qe measured for each of the six repeated adsorption-elution-re-adsorption cycles is shown in the table, wherein Qe 0 Represents the unrepeated adsorption capacity, qe 1 The adsorption capacity after one repeated adsorption cycle is shown, and the results of the repeatability test are shown in fig. 11 and table 10:
table 10 adsorption capacity table for repeatability experiments
After MMPs and MNIPs of HC and P are respectively subjected to adsorption-elution-re-adsorption circulation operation, the adsorption capacity of the four polymers gradually decreases, and the adsorption capacity Qe of MMPs of HC and P is respectively reduced by 4.95% and 4.30% from the first repetition to the sixth repetition; MNIPs for HC and P decreased by 12.13% and 6.076% respectively from the first to the sixth repetition of adsorption capacity Qe.
From the results of MMIPs and MNIPs, it can be seen that the MMIPs recycling rate remains high after six times of repeated use, which indicates that MMIPs have higher stability and reusability than MNIPs, because MMIPs have specific cavities of a fixed shape, and can have stable and specific adsorption capacity for target compounds, so that the MMIPs can maintain high adsorption capacity even in multiple elution-adsorption operations. MNIPS has slightly lower repeatability than MMPs due to non-template blotting, and Qe 0 And are lower than MMPs, and the adsorption performance of the dual-mode MMPs is considered to be more excellent.
(IV) Selectivity test
A plurality of structural analogues similar to Hydrocortisone (HC) are selected to prepare a mixed solution for adsorption test, and the selected structural analogues comprise ursodeoxycholic acid (Canoic), ethinyl Estradiol (EE), deoxynivalenol (DON) and prednisolone (Prednis). 5 samples were mixed in a beaker to prepare mixed solutions each having a concentration of 50. Mu.g/ml, 10mg MMPs and MNIPs were accurately weighed, 2ml of the above mixed solution was added thereto, and the mixture was adsorbed at 25℃for 3 hours. The supernatant was separated by an external magnetic field, passed through a 0.22 μm organic phase microporous membrane, and then used for HPLC to detect the concentration of the above structural analog. The adsorption capacities of MMIPs and MNIPs for each compound were determined, and then the blotting factor IF was calculated to compare the adsorption capacities of the two.
The results of the selectivity experiments are shown in figure 12.
FIG. 12 shows that MMPs and MNIPs have the highest adsorption capacity for template molecules HC and P among the five compounds, and the imprinting factor IF reaches 2.11 and 2.307, respectively. Canoic, EE and DON have similar backbone and functional group structures as HC and P, but polymers have a lower recognition capacity for them. The polymer has no high adsorption capacity to other compounds, can selectively adsorb target molecules HC and P in the mixture, is a material with high selectivity and high specificity, and is suitable for accurately adsorbing HC and P in a complex matrix.
Example 5: application of Magnetic Molecularly Imprinted Polymers (MMIPs) in milk and milk powder
The raw material obtaining sources are as follows: the milk is Deya brand skimmed milk and is purchased in a Jiang Ningou Su fruit supermarket in Nanjing; the milk powder is a formula milk powder for children in the golden collar crown, and is purchased in the Jiang Ningou Su fruit supermarket in Nanjing.
The preparation method of MMPs in this example was the same as in example 1.
Dispersing 1g milk powder in a mixed solution of 45ml acetonitrile and 5ml deionized water, ultrasonically extracting for 10min, oscillating for 10min, centrifuging at a speed of not less than 5000r/min for 15min, and collecting supernatant. The collected supernatant was refrigerated in a refrigerator at 4-8 ℃ and left for a while, filtered again to collect the supernatant. Four standard solutions of HC and P mix with standard levels of 10, 20, 50 and 100ng/ml, respectively, were added to the blank matrix of the milk powder solution described above. To 20ml of the sample solution, 10mg of dual-template MMPs were added, and the pellet was collected by external magnetic field at 25℃for 40min of adsorption with shaking. The eluate was collected with an external magnetic field, eluted with 1ml of methanol/acetic acid (9:1, v/v) solution for 5 minutes, dried with nitrogen, and then redissolved in 1ml of acetonitrile. After passing through a 0.22 μm organic phase microporous filter membrane, loading and analyzing by HPLC, each standard adding level is measured in parallel for 6 times, and the average recovery, recovery rate and precision are obtained.
2g of milk was dispersed in 5ml of acetonitrile, vortexed and mixed for 5min, centrifuged at 10000r/min for 10min, and the supernatant was collected. The collected supernatant was refrigerated in a refrigerator at 4-8 ℃ and left for a while, filtered again to collect the supernatant. Four standard solutions of HC and P mix with standard levels of 10, 20, 50 and 100ng/ml, respectively, were added to the blank matrix of the milk solution. To 50ml of the sample solution, 10mg of dual-template MMPs were added, and the pellet was collected by external magnetic field at 25℃for 40min of adsorption with shaking. The eluate was collected with an external magnetic field, eluted with 1ml of methanol/acetic acid (9:1, v/v) solution for 5 minutes, dried with nitrogen, and then redissolved in 1ml of acetonitrile. After passing through a 0.22 μm organic phase microporous filter membrane, loading and analyzing by HPLC, each standard adding level is measured in parallel for 6 times, and the average recovery, recovery rate and precision are obtained.
The results of the experiment are shown in Table 11.
TABLE 11 sample recovery and precision test results
By comparing the results of the application of the two types of compounds in the samples, the recovery rate of the two sample treatment methods is more than 87%, the precision is within 4%, and the treatment method is proved to be feasible and can be directly applied to the enrichment, purification and detection of HC and P in the milk products.
The above description is only a preferred embodiment of the present invention and the above embodiments are not intended to limit the scope of the present invention, but the present invention is not limited to the above embodiments, and all equivalent modifications, equivalent substitutions and improvements made by those skilled in the art based on the present disclosure should be included in the scope of the present invention.
Claims (10)
1. The preparation method of the dual-template MMPs for specifically adsorbing HC and P is characterized by comprising the following steps of:
s1, preparing Fe with carboxyl on surface by improved hydrothermal method 3 O 4 A nanoparticle;
s2, preparing Fe 3 O 4 @SiO 2 Composite particles;
s3, preparing Fe 3 O 4 @SiO 2 -C=C;
S4, preparing a dual-template magnetic molecularly imprinted polymer: mixing each template molecule with a functional monomer and a pore-forming agent respectively, dissolving, and imprinting at room temperature to obtain a first mixed solution; weighing Fe obtained in the step S3 3 O 4 @SiO 2 -c=c, adding a porogenic agent, uniformly dispersing the magnetic material by ultrasound, and mixing with the first mixed solution to obtain a second mixed solution; then adding a cross-linking agent and an initiator into the second mixed solution in sequence to carry out polymerization reaction; heating after deoxidizing the nitrogen; after the reaction, the product is collected by a magnetic field, dried and Soxhlet extracted to obtain a polymer with a specific cavity, wherein the templateThe molecules are hydrocortisone HC and prednisolone P.
2. The method for preparing dual-template MMIPs for specific adsorption of HC and P according to claim 1, wherein step S1 specifically comprises: adding ferric chloride hexahydrate, trisodium citrate dihydrate and ethylene glycol into a beaker, magnetically stirring at room temperature until solid particles are dissolved, then adding anhydrous sodium acetate, and stirring until the solution is uniform; pouring the solution into a reactor, and reacting for 10 hours at 200 ℃; after the reaction, magnetic particles are separated by applying a magnetic field, repeatedly washed by deionized water and ethanol, and dried to obtain Fe with carboxyl on the surface 3 O 4 A nanoparticle;
the step S2 specifically includes: taking Fe synthesized in the step S1 3 O 4 Dispersing the nano particles in hydrochloric acid solution, carrying out ultrasonic treatment, collecting magnetic materials by using a magnet, and washing to be neutral; dispersing the washed particles in a mixed solution of ethanol and deionized water, respectively adding tetraethyl orthosilicate and 28wt% ammonia water solution into the solution, and stirring at normal temperature for reaction; separating, washing and drying after the reaction to obtain Fe 3 O 4 @SiO 2 Composite particles;
the step S3 specifically includes: taking Fe synthesized in the step S2 3 O 4 @SiO 2 Dispersing composite particles in methanol water solution added with silane coupling agent, stirring, separating, washing and drying to obtain Fe 3 O 4 @SiO 2 -C=C。
3. The method for preparing dual-template MMIPs for specific adsorption of HC and P according to claim 2, wherein the silane coupling agent is γ -methacryloxypropyl trimethoxysilane.
4. The method for preparing dual-template MMIPs for specific adsorption of HC and P according to claim 1, wherein the functional monomer is any one of acrylamide, methacrylic acid, 4-vinylpyridine, itaconic acid.
5. The method for preparing dual-template MMIPs for specific adsorption of HC and P according to claim 1, wherein the porogen is any one of acetonitrile, ethanol, chloroform, tetrahydrofuran.
6. The method for preparing dual-template MMIPs for specific adsorption of HC and P according to claim 1, wherein the time of blotting at room temperature is 3-24 h.
7. The method for preparing dual-template MMIPs for specific adsorption of HC and P according to claim 1, wherein the cross-linking agent is any one of ethylene glycol dimethacrylate, tetraethyl orthosilicate, divinylbenzene; the initiator is 2, 2-azo diisobutyronitrile.
8. The method for preparing dual-template MMPs for specifically adsorbing HC and P according to claim 1, wherein in the step S4, the addition ratio of the template molecule, the functional monomer and the crosslinking agent is 1:1-10:5-50.
9. The method for preparing dual-template MMIPs for specific adsorption of HC and P according to claim 1, characterized in that the polymerization reaction is carried out at a temperature of 55-75 ℃; the reaction time is 3-24 h.
10. The method for preparing dual-template MMIPs for specific adsorption of HC and P according to claim 9, characterized in that the polymerization reaction is carried out at a temperature of 60 ℃; the polymerization reaction was carried out for 6 hours.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310349763.6A CN116253833B (en) | 2023-04-04 | 2023-04-04 | Preparation method of dual-template MMPs for specifically adsorbing HC and P |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310349763.6A CN116253833B (en) | 2023-04-04 | 2023-04-04 | Preparation method of dual-template MMPs for specifically adsorbing HC and P |
Publications (2)
Publication Number | Publication Date |
---|---|
CN116253833A true CN116253833A (en) | 2023-06-13 |
CN116253833B CN116253833B (en) | 2024-02-27 |
Family
ID=86688089
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310349763.6A Active CN116253833B (en) | 2023-04-04 | 2023-04-04 | Preparation method of dual-template MMPs for specifically adsorbing HC and P |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116253833B (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100203138A1 (en) * | 2007-02-21 | 2010-08-12 | Jan Bastiaan Bouwstra | Controlled Release Composition Comprising a Recombinant Gelatin |
US20130306485A1 (en) * | 2011-02-04 | 2013-11-21 | Council Of Scientific & Industrial Research | Molecularly Imprinted Conducting Polymer Film Based Aqueous Amino Acid Sensors |
CN106749830A (en) * | 2016-12-29 | 2017-05-31 | 江苏大学 | A kind of preparation method of magnetic porous molecularly imprinted polymer |
-
2023
- 2023-04-04 CN CN202310349763.6A patent/CN116253833B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100203138A1 (en) * | 2007-02-21 | 2010-08-12 | Jan Bastiaan Bouwstra | Controlled Release Composition Comprising a Recombinant Gelatin |
US20130306485A1 (en) * | 2011-02-04 | 2013-11-21 | Council Of Scientific & Industrial Research | Molecularly Imprinted Conducting Polymer Film Based Aqueous Amino Acid Sensors |
CN106749830A (en) * | 2016-12-29 | 2017-05-31 | 江苏大学 | A kind of preparation method of magnetic porous molecularly imprinted polymer |
Non-Patent Citations (3)
Title |
---|
PRIYANKA SIWACH • ANITA RANI GILL: "Micropropagation ofFicus religiosaL. via leaf explants and comparative evaluation of acetylcholinesterase inhibitory activity in the micropropagated and conventionally grown plants", 《3 BIOTECH》, vol. 2013, 4 October 2013 (2013-10-04), pages 1 - 15 * |
WONGDUAN SROYSEE, ETC.: "Molecularly imprinted polymers to detect profenofos and carbofuran selectively with QCM sensors", 《PHYSICS IN MEDICINE》, 12 December 2019 (2019-12-12), pages 1 - 30 * |
盖青青;屈锋;: "牛血清白蛋白和溶菌酶为双模板蛋白质的表面印迹聚合物的制备及吸附性能", 色谱, no. 05, 8 May 2015 (2015-05-08), pages 41 - 46 * |
Also Published As
Publication number | Publication date |
---|---|
CN116253833B (en) | 2024-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Zhang et al. | Novel molecularly imprinted polymers based on multi-walled carbon nanotubes with binary functional monomer for the solid-phase extraction of erythromycin from chicken muscle | |
Wang et al. | Magnetic molecularly imprinted nanoparticles based on dendritic-grafting modification for determination of estrogens in plasma samples | |
Wang et al. | The preparation of high-capacity boronate affinity adsorbents by surface initiated reversible addition fragmentation chain transfer polymerization for the enrichment of ribonucleosides in serum | |
Xu et al. | Synthesis of surface molecular imprinted polymers based on carboxyl-modified silica nanoparticles with the selective detection of dibutyl phthalate from tap water samples | |
CN103497276B (en) | A kind of preparation method and application of carbon nanotube-based magnetic organic phosphorous molecule imprinted polymer | |
Liang et al. | Ordered macroporous molecularly imprinted polymers prepared by a surface imprinting method and their applications to the direct extraction of flavonoids from Gingko leaves | |
Kartal et al. | Molecularly imprinted cryogel beads for cholesterol removal from milk samples | |
An et al. | Novel ionic surface imprinting technology: design and application for selectively recognizing heavy metal ions | |
Sun et al. | A restricted access molecularly imprinted polymer coating on metal–organic frameworks for solid-phase extraction of ofloxacin and enrofloxacin from bovine serum | |
Lv et al. | Adsorption-controlled preparation of molecularly imprinted hybrid composites for selective extraction of tetracycline residues from honey and milk | |
Liang et al. | Amido surface-functionalized magnetic molecularly imprinted polymers for the efficient extraction of Sibiskoside from Sibiraea angustata | |
Yang et al. | Self-driven BSA surface imprinted magnetic tubular carbon nanofibers: fabrication and adsorption performance | |
Elabboudi et al. | Adsorption performance and mechanism of anionic MO dye by the adsorbent polymeric Amberlite® IRA-410 resin from environment wastewater: Equilibrium kinetic and thermodynamic studies | |
CN105153367A (en) | Preparation method of dicyandiamide mesoporous surface molecularly imprinted polymer microspheres | |
Dolak | Selective separation and preconcentration of Thorium (IV) in bastnaesite ore using Thorium (IV)-Imprinted cryogel polymer | |
Saylan et al. | Monolithic boronate affinity columns for IgG separation | |
CN112979893B (en) | Preparation of magnetic fluorescent material @ molecularly imprinted particle and method for preparing composite membrane by using same | |
Dursun et al. | Synthesis of novel monolithic cartridges with specific recognition sites for extraction of melamine | |
CN116253833B (en) | Preparation method of dual-template MMPs for specifically adsorbing HC and P | |
CN115920864B (en) | Magnetic amino functional core-shell composite material and preparation method thereof | |
CN102731706A (en) | Carbofuran molecularly imprinted microspheres, preparation and application thereof | |
CN112552469B (en) | Preparation method of bisphenol A magnetic molecularly imprinted polymer and application of bisphenol A magnetic molecularly imprinted polymer in bisphenol A fluorescence detection | |
Panahi et al. | Fabrication of new drug imprinting polymer beads for selective extraction of naproxen in human urine and pharmaceutical samples | |
Zhang et al. | Synthesis of a magnetic micelle molecularly imprinted polymers to selective adsorption of rutin from Sophora japonica | |
Zhang et al. | Synthesizing molecularly imprinted polymer beads for the purification of vitamin E |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |